Cite
HARVARD Citation
Cousin, S. et al. (2022). Regorafenib–avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial. European journal of cancer. pp. 161-169. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cousin, S. et al. (2022). Regorafenib–avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial. European journal of cancer. pp. 161-169. [Online].